DocGo (DCGO) Stock Forecast & Price Target

DocGo is a growing company with a strong foundation in its core Transportation segment and the addition of virtual care through the acquisition of SteadyMD providing a compelling offering. Their discounted valuation, currently at a 0.2x multiple of estimated revenue, may be justified until they can show stronger growth and profitability in their core payer business. However, the potential for strategic alternatives and a sum-of-the-parts valuation could drive the value per share higher.

DocGo is expected to face challenges in the coming years due to the decline of revenue and margins in its Mobile Health Services segment, which has a reliance on lower-margin migrant-related revenue. Additionally, the company will need to significantly reduce operating expenses in order to achieve its low-end guidance for adjusted EBITDA in 2026. With uncertainty surrounding post-pandemic demand and the potential dissipation of testing revenue, there are risks to the company's growth projections. Further, while the company's differentiated business model and integration of a logistics platform and lower-cost staffing could position it for success, there is still a transition period for the company and it may face challenges in meeting its forecasts.